Overview A Study of E7130 in Participants With Solid Tumors Status: Recruiting Trial end date: 2023-03-31 Target enrollment: Participant gender: Summary The primary objective of this study is to evaluate the tolerability and safety profile of E7130 in participants with advanced solid tumors. Phase: Phase 1 Details Lead Sponsor: Eisai Co., Ltd.